% alzhub.org library filter
% Source: https://alzhub.org/research?author=Schneider+LS&access=free
% 18 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{green2009-20009055,
  author  = {Green, R. C. and Schneider, L. S. and Amato, D. A. and Beelen, A. P. and Wilcock, G. and Swabb, E. A. and Zavitz, K. H. and {Tarenflurbil Phase 3 Study Group}},
  title   = {{Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial}},
  journal = {JAMA},
  year    = {2009},
  doi     = {10.1001/jama.2009.1866},
  pmid    = {20009055},
  url     = {https://doi.org/10.1001/jama.2009.1866}
}

@article{aisen2008-18854539,
  author  = {Aisen, P. S. and Schneider, L. S. and Sano, M. and Diaz-Arrastia, R. and van Dyck, C. H. and Weiner, M. F. and Bottiglieri, T. and Jin, S. and others},
  title   = {{High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial}},
  journal = {JAMA},
  year    = {2008},
  doi     = {10.1001/jama.300.15.1774},
  pmid    = {18854539},
  url     = {https://doi.org/10.1001/jama.300.15.1774}
}

@article{rajji2025-40133524,
  author  = {Rajji, T. K. and Baksh, S. N. and Shade, D. M. and Ismail, Z. and Burhan, A. M. and Okhravi, H. R. and Padala, P. R. and Rosenberg, P. B. and Schneider, L. S. and Porsteinsson, A. P. and others},
  title   = {{Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial}},
  journal = {Nature Medicine},
  year    = {2025},
  doi     = {10.1038/s41591-025-03569-y},
  pmid    = {40133524},
  url     = {https://doi.org/10.1038/s41591-025-03569-y}
}

@article{rosenberg2010-20087081,
  author  = {Rosenberg, P. B. and Drye, L. T. and Martin, B. K. and Frangakis, C. and Mintzer, J. E. and Weintraub, D. and Porsteinsson, A. P. and Schneider, L. S. and others},
  title   = {{Sertraline for the treatment of depression in Alzheimer disease}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2010},
  doi     = {10.1097/jgp.0b013e3181c796eb},
  pmid    = {20087081},
  url     = {https://doi.org/10.1097/jgp.0b013e3181c796eb}
}

@article{tariot2011-21810649,
  author  = {Tariot, P. N. and Schneider, L. S. and Cummings, J. and Thomas, R. G. and Raman, R. and Jakimovich, L. J. and Loy, R. and Bartocci, B. and others},
  title   = {{Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease}},
  journal = {Archives of general psychiatry},
  year    = {2011},
  doi     = {10.1001/archgenpsychiatry.2011.72},
  pmid    = {21810649},
  url     = {https://doi.org/10.1001/archgenpsychiatry.2011.72}
}

@article{maust2015-25786075,
  author  = {Maust, D. T. and Kim, H. M. and Seyfried, L. S. and Chiang, C. and Kavanagh, J. and Schneider, L. S. and Kales, H. C.},
  title   = {{Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm}},
  journal = {JAMA psychiatry},
  year    = {2015},
  doi     = {10.1001/jamapsychiatry.2014.3018},
  pmid    = {25786075},
  url     = {https://doi.org/10.1001/jamapsychiatry.2014.3018}
}

@article{schneider2014-24605808,
  author  = {Schneider, L. S. and Mangialasche, F. and Andreasen, N. and Feldman, H. and Giacobini, E. and Jones, R. and Mantua, V. and Mecocci, P. and others},
  title   = {{Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014}},
  journal = {Journal of internal medicine},
  year    = {2014},
  doi     = {10.1111/joim.12191},
  pmid    = {24605808},
  url     = {https://doi.org/10.1111/joim.12191}
}

@article{schneider2019-31492718,
  author  = {Schneider, L. S. and Geffen, Y. and Rabinowitz, J. and Thomas, R. G. and Schmidt, R. and Ropele, S. and Weinstock, M. and {Ladostigil Study Group}},
  title   = {{Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial}},
  journal = {Neurology},
  year    = {2019},
  doi     = {10.1212/wnl.0000000000008239},
  pmid    = {31492718},
  url     = {https://doi.org/10.1212/wnl.0000000000008239}
}

@article{mengel2025-40247130,
  author  = {Mengel, D. and Soter, E. and Ott, J. M. and Wacker, M. and Leyva, A. and Peters, O. and Hellmann-Regen, J. and Schneider, L. S. and others},
  title   = {{Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease}},
  journal = {Molecular psychiatry},
  year    = {2025},
  doi     = {10.1038/s41380-025-03021-0},
  pmid    = {40247130},
  url     = {https://doi.org/10.1038/s41380-025-03021-0}
}

@article{schneider2016-26771737,
  author  = {Schneider, L. S. and Frangakis, C. and Drye, L. T. and Devanand, D. P. and Marano, C. M. and Mintzer, J. and Mulsant, B. H. and Munro, C. A. and others},
  title   = {{Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial}},
  journal = {The American journal of psychiatry},
  year    = {2016},
  doi     = {10.1176/appi.ajp.2015.15050648},
  pmid    = {26771737},
  url     = {https://doi.org/10.1176/appi.ajp.2015.15050648}
}

@article{schneider2011-21220675,
  author  = {Schneider, L. S. and Insel, P. S. and Weiner, M. W. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative}},
  journal = {Archives of neurology},
  year    = {2011},
  doi     = {10.1001/archneurol.2010.343},
  pmid    = {21220675},
  url     = {https://doi.org/10.1001/archneurol.2010.343}
}

@article{mohamed2012-21939611,
  author  = {Mohamed, S. and Rosenheck, R. and Lyketsos, C. G. and Kaczynski, R. and Sultzer, D. L. and Schneider, L. S.},
  title   = {{Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease}},
  journal = {The Journal of clinical psychiatry},
  year    = {2012},
  doi     = {10.4088/jcp.10m06574},
  pmid    = {21939611},
  url     = {https://doi.org/10.4088/jcp.10m06574}
}

@article{tariot2018-29955659,
  author  = {Tariot, P. N. and Lopera, F. and Langbaum, J. B. and Thomas, R. G. and Hendrix, S. and Schneider, L. S. and Rios-Romenets, S. and Giraldo, M. and others},
  title   = {{The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2018},
  doi     = {10.1016/j.trci.2018.02.002},
  pmid    = {29955659},
  url     = {https://doi.org/10.1016/j.trci.2018.02.002}
}

@article{schneider2019-31282954,
  author  = {Schneider, L. S. and Thomas, R. G. and Hendrix, S. and Rissman, R. A. and Brewer, J. B. and Salmon, D. P. and Oltersdorf, T. and Okuda, T. and others},
  title   = {{Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.1868},
  pmid    = {31282954},
  url     = {https://doi.org/10.1001/jamaneurol.2019.1868}
}

@article{yassine2017-28114437,
  author  = {Yassine, H. N. and Braskie, M. N. and Mack, W. J. and Castor, K. J. and Fonteh, A. N. and Schneider, L. S. and Harrington, M. G. and Chui, H. C.},
  title   = {{Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review}},
  journal = {JAMA neurology},
  year    = {2017},
  doi     = {10.1001/jamaneurol.2016.4899},
  pmid    = {28114437},
  url     = {https://doi.org/10.1001/jamaneurol.2016.4899}
}

@article{mohamed2010-20808108,
  author  = {Mohamed, S. and Rosenheck, R. and Lyketsos, C. G. and Schneider, L. S.},
  title   = {{Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2010},
  doi     = {10.1097/jgp.0b013e3181d5745d},
  pmid    = {20808108},
  url     = {https://doi.org/10.1097/jgp.0b013e3181d5745d}
}

@article{schneider2010-20813339,
  author  = {Schneider, L. S. and Kennedy, R. E. and Cutter, G. R. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2010},
  doi     = {10.1016/j.jalz.2010.07.004},
  pmid    = {20813339},
  url     = {https://doi.org/10.1016/j.jalz.2010.07.004}
}

@article{schneider2009-19812469,
  author  = {Schneider, L. S. and Raman, R. and Schmitt, F. A. and Doody, R. S. and Insel, P. and Clark, C. M. and Morris, J. C. and Reisberg, B. and others},
  title   = {{Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2009},
  doi     = {10.1097/wad.0b013e31819cb760},
  pmid    = {19812469},
  url     = {https://doi.org/10.1097/wad.0b013e31819cb760}
}